Anthranilate Reduces Pseudomonas aeruginosa Infection Severity Through an Antibiotic-Independent Anti-Virulence Mechanism
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- ANTIBIOTICS-BASEL15(9) · #898 · 2026
- 피인용
- Web of Science 0Scopus 0
- JCR IF
- JCR 2024 4.6
- ISSN
- 2079-6382
저자
초록
Background/Objectives: Antibiotic resistance is a growing global health challenge, especially with tricky bacteria like Pseudomonas aeruginosa. Anthranilate, previously identified as a signaling molecule in P. aeruginosa, modulates various pathogenicity-related phenotypes by reducing virulence factor production, inhibiting biofilm formation, and increasing antibiotic susceptibility. Based on these good properties as an anti-virulence agent, this study evaluated the actual therapeutic potential of anthranilate using mouse skin infection and lung infection models. Specifically, the efficacy of anthranilate in a standalone treatment was investigated without reliance on conventional antibiotics. Methods: The therapeutic efficacy of anthranilate was evaluated in murine skin and lung infection models of P. aeruginosa. Anthranilate was administered as a standalone treatment, and its effects on bacterial burden, inflammatory responses, and tissue lesion progression were assessed and compared with those of gentamicin treatment. Results: Anthranilate effectively reduced bacterial suppuration, mitigated inflammatory responses, and suppressed lesion progression in infected skin and lung tissues. Notably, anthranilate alone produced therapeutic effects comparable to those of gentamicin. Conclusions: These findings highlight its potential of standalone treatment as an alternative to traditional antibiotics and offer a novel anti-virulence strategy that minimizes selective pressure for resistance development.
키워드
Pseudomonas aeruginosaanthranilateanti-virulence agentquorum sensingmouse skin infectionmouse pulmonary infectionTARGETING VIRULENCEBACTERIAL BIOFILMSGROWTH-PHASESTRATEGIESRESISTANCEPROSPECTSCOMBAT
식별자
- Scopus EID
- 2-s2.0-105051394963
- WoS UID
- 001890845100001



로그인
연구물 목록으로